4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-26-000073
Chief Legal Officer sold 17,824 shares at an average $38.31 ($682,887)
- Chief Legal Officer acquired 17,824 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Van Tuyl Christopher Chief Legal Officer | 2026-06-26 | Option exercise | +17,824 | $15.20 | $270,925 | 198,421 | D |
| Van Tuyl Christopher Chief Legal Officer | 2026-06-26 | Sale | −14,982 | $38.19 | $572,163 | 183,439 | D |
| Van Tuyl Christopher Chief Legal Officer | 2026-06-26 | Sale | −2,842 | $38.96 | $110,724 | 180,597 | D |
| Derivatives | |||||||
| Van Tuyl Christopher Chief Legal Officer | 2026-06-26 | Option exercise · Stock Option (right to buy) | −17,824 | 53,707 | D | ||
| Open-market sales · 17,824 sh · avg $38.31 · $682,887 | |||||||
Loading xslF345X06/wk-form4_1782517498.xml…